April 2009
Volume 50, Issue 13
ARVO Annual Meeting Abstract  |   April 2009
Triamcinolone Acetonide Preparations: Impact of Crystal Size Upon in vitro Behavior
Author Affiliations & Notes
  • S. R. Sanislo
    Ophthalmology, Stanford University, Menlo Park, California
  • A. A. Moshfeghi
    Department of Ophthalmology, University of Miami Miller School of Medicine, Bascom Palmer Eye Institute, Miami, Florida
  • A. K. Nugent
    Ophthalmology, Stanford University, Menlo Park, California
  • H. Nomoto
    Ophthalmology, Stanford University, Menlo Park, California
  • J. W. Kitchens
    Retina Associates of Kentucky, Lexington, Kentucky
  • D. M. Moshfeghi
    Ophthalmology, Stanford University, Menlo Park, California
  • Footnotes
    Commercial Relationships  S.R. Sanislo, None; A.A. Moshfeghi, None; A.K. Nugent, None; H. Nomoto, None; J.W. Kitchens, None; D.M. Moshfeghi, None.
  • Footnotes
    Support  Research funding provided by The Palm Beach Community Trust Fund
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 5022. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. R. Sanislo, A. A. Moshfeghi, A. K. Nugent, H. Nomoto, J. W. Kitchens, D. M. Moshfeghi; Triamcinolone Acetonide Preparations: Impact of Crystal Size Upon in vitro Behavior. Invest. Ophthalmol. Vis. Sci. 2009;50(13):5022.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To characterize the in vitro behavior of 3 preparations of triamcinolone acetonide.

Methods: : Three preparations of triamcinolone acetonide were mixed with Balanced Salt Solution Plus (BSS Plus): commercially available triamcinolone acetonide (TA), compounded preservative-free triamcinolone acetonide (PFTA), and triamcinolone acetonide injectable suspension (TAIS). We determined mean number of crystalline aggregates per high power deconvolution microscopy field, largest aggregate area, and spectroscopic photometric absorption (SPA).

Results: : PFTA had larger mean number of aggregates compared to TA (time zero p=0.002, 10 minutes p<0.001) and TAIS (time zero p<0.001, 10 minutes p=0.003). Aggregate size varied at both 0 and 10 minutes: TAIS > TA > PFTA. SPA decreased in direct correlation to aggregate size over time for all 3 preparations.

Conclusions: : PFTA in BSS Plus has more aggregates of smaller size than TA and TAIS. TAIS has much larger aggregate size than PFTA and TA, and increases over time. These findings correlate with the observation that TA tends to spread more evenly throughout the vitreous and epiretinal membrane and internal limiting membrane, and TAIS lacks diffuse distribution, instead gravitating toward the most dependent portion of the eye in a globular fashion.

Keywords: vitreoretinal surgery • injection • vitreous 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.